TITLE

Secondary immune-mediated thrombocytopenia in dogs naturally infected by Leishmania infantum

AUTHOR(S)
Cortese, L.; Sica, M.; Piantedosi, D; Ruggiero, G.; Pero, M. E.; Terrazzano, G.; Mastellone, V.; Ciaramella, P.
PUB. DATE
June 2009
SOURCE
Veterinary Record: Journal of the British Veterinary Association;6/20/2009, Vol. 164 Issue 25, p778
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Forty-four dogs naturally infected by Leishmania infantum were divided into two groups: 20 thrombocytopenic dogs with fewer than 150 x 109 platelets/I, and 24 non-thrombocytopenlc dogs with more than 200 x 109 platelets/I. Ten clinically healthy dogs were used as controls. A haematological profile was obtained and the dogs' serum was used to assess the presence of platelet-binding IgM and lgG antibodies using a flow cytometry technique. Nineteen of the 20 thrombocytopenic dogs, and 13 of the 24 non-thrombocytopenic dogs had detectable levels of platelet-binding immunoglobulins, but none of the control dogs did so. The differences were significantly different for both IgM and lgG platelet-binding antibodies.
ACCESSION #
43153184

 

Related Articles

  • Synthetic Pentasaccharides Do Not Cause Platelet Activation by Antiheparin-Platelet Factor 4 Antibodies. Ahmad, Sarfraz; Jeske, Walter P.; Walenga, Jeanine M.; Hoppensteadt, Debra A.; Wood, Jennifer J.; Herbert, Jean-Marc; Messmore, Harry L.; Fareed, Jawed // Clinical & Applied Thrombosis/Hemostasis;Oct1999, Vol. 5 Issue 4, p259 

    A synthetic selective inhibitor of factor Xa, the pentasaccharide SR90107A/Org31540 is in clinical development for the prophylaxis of postsurgical deep vein thrombosis. Another synthetic pentasaccharide with even more sustained inhibition of factor Xa, SanOrg34006, has also been developed. Both...

  • Use of intravenous immunoglobulin in severe refractory idiopathic immune thrombocytopenia. Maharaj, D.; McKillop, J. H. // Journal of the Royal Society of Medicine;Oct1987, Vol. 80 Issue 10, p652 

    The article presents information on cases about the use of intravenous immunoglobulin in severe refractory idiopathic immune thrombocytopenia (ITP). ITP is said to be a disorder which may be associated with morbidity and a mortality rate of 5%. The use of high-dose intravenous immunoglobulin has...

  • Usefulness of Measurement of Reticulated Platelets for Diagnosis of Idiopathic Thrombocytopenic Purpura. Sakakura, Miho; Wada, Hideo; Abe, Yasunori; Nishioka, Junji; Tomatsu, Hiroaki; Hamaguchi, Yukio; Oguni, Shinichiro; Shiku, Hiroshi; Nobori, Tsutomu // Clinical & Applied Thrombosis/Hemostasis;Jul2005, Vol. 11 Issue 3, p253 

    Reticulated platelets (RP) and large platelets (LP) were measured by an automated hematology analyzer (modified R-2000) in 287 healthy volunteers and 131 patients with thrombocytopenia or thrombocytosis, RP was significantly higher in patients with idiopathic thrombocytopenic purpura (ITP),...

  • Heparin.  // Reactions Weekly;11/15/2008, Issue 1228, p20 

    The article describes the case of a 49-year-old man who was diagnosed with heparin-induced thrombocytopenia (HIT) antibodies. The patient tested positive for the said condition while undergoing treatment with intravenous (IV) heparin. He was subjected to thrombectomy and was administered with...

  • Vancomycin-dependent antibodies implicated in thrombocytopenia.  // Reactions Weekly;3/10/2007, Issue 1142, p6 

    The article offers information on the results of a research on thrombocytopenia among patients receiving the vancomycin-dependent antiplatelet antibodies. It mentions that the presence of antibodies in the serum samples of 34 patients were found by researchers. It says that the platelet levels...

  • Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up. Mirzania, Mehrzad; Khalili, Sedigheh; Hasanpoor, Akbar; Reza Shamshiri, Ahmad // International Journal of Hematology-Oncology & Stem Cell Researc;Apr2014, Vol. 8 Issue 2, p41 

    Amegakaryocytic thrombocytopenia (AMT) is a rare cause of acquired thrombocytopenia. The pathogenesis and treatment of AMT is not clearly known. Here we demonstrate a 50-year-old man presented with the clinical manifestations of severe thrombocytopenia (7000 platelets/μl) with a marked...

  • Idiopathic Thrombocytopenic Purpura In Infants Under 6 Months of Age. Özsoylu, Sinasi; Onat, Nese // Clinical Pediatrics;Oct1992, Vol. 31 Issue 10, p626 

    The article cites a study which focused on idiopathic thrombocytopenic purpura (ITP) in infants under 6 months of age. Among the 269 patients with ITP seen at Hacettepe Children's Hospital between 1973 and 1987, only 7 were younger than 6 months. However, between June 1987 and June 1989 in this...

  • Drug-induced immune thrombocytopenia. van den Bemt, Patricia M. L. A.; Meyboom, Ronald H. B.; Egberts, Antoine C. G. // Drug Safety;2004, Vol. 27 Issue 15, p1243 

    Thrombocytopenia can have several causes, including the use of certain drugs. The mechanism behind drug-induced thrombocytopenia is either a decrease in platelet production (bone marrow toxicity) or an increased destruction (immune-mediated thrombocytopenia). In addition, pseudothrombocytopenia,...

  • Rosettes in Idiopathic thrombocytopenic purpura - An Unusual Observation. Mathew, Mary; Goel, Garima // Internet Journal of Hematology;2009, Vol. 6 Issue 1, p5 

    Rosettes in the bone marrow can be seen in various malignancies. We report an unusual observation of leukocytes rosetting around megakaryocytes in a child with Immune thrombocytopenic purpura.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics